PTPN2 and breast cancer: By contrast, the deletion of PTPN2 in aggressive E0771 mammary tumors which exhibit heightened IFNγ/IFNβ expression, STAT-1 signaling, and T cell infiltrates independent of PTPN2 status, as well as a robust immunosuppressive tumor microenvironment, had no effect on tumor growth10.